Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 5252 · Having Overdose Protection Equipment Act ·

HOPE Act

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

42 U.S.C. § 290ee–3a Grant program for State and Tribal response to opioid use disorders

+11 −53 of 4 shown
More for 42 U.S.C. § 290ee–3a
Read § 290ee–3aOnly this section
4 changes the bill asks for here, 3 carried out
  1. Carried out:

    in subsection (b)(4)(A), by inserting and other activities related to acquiring, making available, and maintaining public access opioid overdose reversal kits after primary prevention activities; and

  2. Carried out:

    by redesignating paragraphs (2) and (4) as paragraphs (4) and (5), respectively;

  3. Not carried out:

    by transferring paragraph (4), as so redesignated, so as to appear after paragraph (3); and

    We can't read how this instruction is worded yet, so it isn't shown in the text.

    Technical detailno-pattern: transferring paragraph (X), as so redesignated, so as to appear after paragraph (X); and
  4. Carried out:

    by inserting after paragraph (1) the following:(2) Public access opioid overdose reversal kit.— The term “public access opioid overdose reversal kit” means a kit that includes— (A) opioid overdose reversal medication; and (B) instructions on how to administer such medication..

§ 290ee–3a(b)(4)Use of funds(A)–(C)

Start of § 290ee–3a to (b)(3)(B)(iii) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(4)(4) Use of funds(4) Use of funds
Grants awarded under this subsection shall be used for carrying out activities that supplement activities pertaining to opioid misuse and use disorders and, as applicable and appropriate, stimulant misuse and use disorders (including co-occurring substance misuse and use disorders), undertaken by the entities described in paragraph (1), which may include public health-related activities such as the following:Grants awarded under this subsection shall be used for carrying out activities that supplement activities pertaining to opioid misuse and use disorders and, as applicable and appropriate, stimulant misuse and use disorders (including co-occurring substance misuse and use disorders), undertaken by the entities described in paragraph (1), which may include public health-related activities such as the following:
(A)(A) (A)
Implementing substance use disorder and overdose prevention activities, including primary prevention activities, and evaluating such activities to identify effective strategies to prevent substance use disorders and overdoses, which may include drugs or devices approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.].Implementing substance use disorder and overdose prevention activities, including primary prevention activities[inserted: and other activities related to acquiring], [inserted: making available, ]and [inserted: maintaining public access opioid overdose reversal kits, and ]evaluating such activities to identify effective strategies to prevent substance use disorders and overdoses, which may include drugs or devices approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.].
(B)(B) (B)
Establishing or improving prescription drug monitoring programs.Establishing or improving prescription drug monitoring programs.
(C)(C) (C)
Training for health care practitioners, such as best practices for prescribing opioids, pain management, recognizing potential cases of substance use disorders, referral of patients to treatment programs, preventing diversion of controlled substances, and overdose prevention.Training for health care practitioners, such as best practices for prescribing opioids, pain management, recognizing potential cases of substance use disorders, referral of patients to treatment programs, preventing diversion of controlled substances, and overdose prevention.

§ 290ee–3a(h)–(i)

(b)(4)(D)–(g) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(h)(h) Definitions(h) Definitions
In this section:In this section:
(h)(1)(1) Indian Tribe(1) Indian Tribe
The term “Indian Tribe” has the meaning given the term “Indian tribe” in section 5304 of title 25.The term “Indian Tribe” has the meaning given the term “Indian tribe” in section 5304 of title 25.
(h)(2)(2) [inserted: Public access opioid overdose reversal kit.—]
[inserted: The term “public access opioid overdose reversal kit” means a kit that includes—]
(h)(2)(A)(A) [inserted: ]
[inserted: opioid overdose reversal medication; and]
(h)(2)(B)(B) [inserted: ]
[inserted: instructions on how to administer such medication.]
(h)(4)[struck: (2)] Tribal organization[inserted: (4)] Tribal organization
The term “Tribal organization” has the meaning given the term “tribal organization” in section 5304 of title 25.The term “Tribal organization” has the meaning given the term “tribal organization” in section 5304 of title 25.
(h)(3)(3) State(3) State
The term “State” has the meaning given such term in section 300x–64(b) of this title.The term “State” has the meaning given such term in section 300x–64(b) of this title.
(h)(5)[struck: (4)] Urban Indian organization[inserted: (5)] Urban Indian organization
The term “Urban Indian organization” has the meaning given such term in section 1603 of title 25.The term “Urban Indian organization” has the meaning given such term in section 1603 of title 25.
(i)(i) Authorization of appropriations(i) Authorization of appropriations
(i)(1)(1) In general(1) In general
For purposes of carrying out the grant program under subsection (b), there is authorized to be appropriated $1,750,000,000 for each of fiscal years 2023 through 2027.For purposes of carrying out the grant program under subsection (b), there is authorized to be appropriated $1,750,000,000 for each of fiscal years 2023 through 2027.

Rest of § 290ee–3a unchanged

Step through the changes